Results 91 to 100 of about 20,877 (183)

The Therapeutic Benefit of Allopurinol in the Treatment of Foreign Body Granulomas Caused by Polymethylmethacrylate Microspheres. [PDF]

Plast Reconstr Surg Glob Open
Alsairefi S, Alqallaf N, Ali S, Mohammad J, Albutti B, Alawadhi R, Alqallaf A, Burezq H.   +7 more
europepmc   +1 more source

Gout Flare in Hospitalized Patients: Risk Factors and the Impact of Allopurinol Management. [PDF]

Cureus
Hassas Yeganeh M, Attabi A, Jumaah O, Saleh W, Malik A, Ara B, Prabhakaran S.   +6 more
europepmc   +1 more source

Establishment and phenotypic characterization of a rat model with a clinically relevant phenotype for chronic gouty arthritis. [PDF]

Front Immunol
Xie C, Huang Y, Fang J, Liu M, Gao Y, Zhao L, Wang H, Yang K, Wang H.   +8 more
europepmc   +1 more source

Successful Extended Allopurinol Desensitization in an Elderly Patient With Chronic Kidney Disease and Febuxostat Intolerance. [PDF]

Cureus
Ramesh R, Nagaraja V, Gonzalez-Estrada A.   +2 more
europepmc   +1 more source

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source

Buddleja officinalis as a natural xanthine oxidase inhibitor in a murine hyperuricemia model. [PDF]

J Vet Med Sci
Wang CC, Lin CE, Huang CJ, Chen HC, Tseng MC, Chen FA.   +5 more
europepmc   +1 more source

Effect of allopurinol and oxypurinol treatment on apoptosis in an experimental testicular torsion model. [PDF]

Ulus Travma Acil Cerrahi Derg
Bilaloglu E, Duman L, Erzurumlu Y, Ertunc O, Kart Y.   +4 more
europepmc   +1 more source

Cluster-Defined Metabolic Heterogeneity and Longitudinal Effects of Allopurinol and SGLT2 Inhibitors in Hyperuricemic Type 2 Diabetes. [PDF]

Med Sci (Basel)
Fejes R, Jámbor T, Szabó A, Tallósy SP.   +3 more
europepmc   +1 more source

Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review. [PDF]

Nephrology (Carlton)
Kamel N, Castelino R, Wright D, Sud K, Tarafdar S, Hughes S, Stocker S.   +6 more
europepmc   +1 more source

Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining. [PDF]

Front Pharmacol
Yang H, Xu J, Zhang J, Zhang X, Jin C, Dai H, Yang M.   +6 more
europepmc   +1 more source